Georgia Healthcare Group (GHG) Price Target Increased to GBX 400 by Analysts at Jefferies Group
Georgia Healthcare Group (LON:GHG) had its price objective lifted by analysts at Jefferies Group from GBX 370 ($4.95) to GBX 400 ($5.35) in a report issued on Monday, December 4th. The brokerage presently has a “buy” rating on the stock. Jefferies Group’s price objective indicates a potential upside of 11.42% from the stock’s current price.
A number of other analysts also recently issued reports on GHG. Numis Securities reaffirmed an “add” rating and set a GBX 420 ($5.62) price objective on shares of Georgia Healthcare Group in a report on Tuesday, August 15th. Berenberg Bank initiated coverage on shares of Georgia Healthcare Group in a report on Tuesday, August 22nd. They set a “buy” rating and a GBX 504 ($6.74) price objective for the company.
Georgia Healthcare Group (LON:GHG) remained flat at $GBX 359 ($4.80) during midday trading on Monday. Georgia Healthcare Group has a 52-week low of GBX 290 ($3.88) and a 52-week high of GBX 403.50 ($5.40). The firm has a market cap of $470.95 and a PE ratio of 5,983.33.
About Georgia Healthcare Group
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.